Market Trends BridgeBio prices offering of $500 million convertible senior notes due 2031 (BBIO:NASDAQ)By admin8996erT0allFebruary 26, 2025 BridgeBio Pharma (NASDAQ:BBIO) Wednesday announced the pricing of $500 million aggregate principal amount of 1.75% convertible senior notes due 2031…
